Evotec SE (ETR:EVT – Get Free Report) dropped 1.6% on Tuesday . The stock traded as low as €8.64 ($9.28) and last traded at €8.69 ($9.34). Approximately 592,764 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 1,360,000 shares. The stock had previously closed at €8.83 ($9.49).
Evotec Stock Down 1.6 %
The company has a debt-to-equity ratio of 55.91, a current ratio of 1.94 and a quick ratio of 2.97. The firm has a 50-day simple moving average of €10.80 and a two-hundred day simple moving average of €14.19. The company has a market cap of $1.54 billion, a PE ratio of -17.37, a P/E/G ratio of 0.98 and a beta of 1.17.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Featured Articles
- Five stocks we like better than Evotec
- Top Stocks Investing in 5G Technology
- What is a Liquidity Trap? Here’s What You Should Know
- What Does Downgrade Mean in Investing?
- Top 3 High-Yield Stocks with Strong Analyst Ratings
- How to Calculate Stock Profit
- 3 Stocks to Watch: Chip Shortage Impact on Industries
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
